Pulmonary Disease, Chronic Obstructive
Conditions
Interventions
A randomized clinical trial will be conducted with 44 participants starting from the approval date of the Research Ethics Committee of the University Hospital of the Federal University of Juiz de Fora
G11.427.410.698.277
Sponsors
Universidade Federal de Juiz de Fora
Hospital Universitário da Universidade Federal de Juiz de Fora
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Individuals with a diagnosis of Chronic Obstructive Pulmonary Disease (COPD); without any other respiratory diseases; of both sexes; aged 18 years or older; clinically stable; without unstable cardiovascular diseases; without neurological disorders; without musculoskeletal diseases; and capable of undergoing the proposed assessments and interventions
Exclusion criteria
Exclusion criteria: Individuals who experience respiratory, cardiovascular, or musculoskeletal complications during assessments and interventions; exacerbation of pulmonary disease; the need for hospitalization; individuals who express their desire to withdraw from the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| An improvement in the perception of happiness is expected, evaluated by the "Subjective Happiness Scale," with an increase of at least 5.13 points. Data will be collected one week before the intervention and one week after the intervention.;An improvement in the perception of happiness is expected, evaluated by the "Cantril's Happiness Scale," with an increase of at least 1 point. Data will be collected one week before the intervention and one week after the intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| An improvement in the perception of life satisfaction is expected, evaluated by the "Life Satisfaction Scale," with an increase of at least 10% in its total score. Data will be collected one week before the intervention and one week after the intervention.;An improvement in peripheral muscle strength is expected, evaluated by dynamometry, with an increase of at least 5kgf. Data will be collected one week before the intervention and one week after the intervention.;An improvement in peripheral muscle strength is expected, evaluated by the "30s Sit-to-Stand Test," with an increase of at least 2 repetitions performed. Data will be collected one week before the intervention and one week after the intervention.;An improvement in functional capacity is expected, evaluated by the "Six-Minute Walk Test," with an increase of at least 30 meters in the distance covered. Data will be collected one week before the intervention and one week after the intervention.;An improvement in functional capacity is expected, evaluated by the "Timed Up and Go (TUG) Test," with an decrease of at least 3,4 seconds. Data will be collected one week before the intervention and one week after the intervention.;An improvement in dyspnea is expected, evaluated by the modified Medical Research Council Dyspnea Scale, with an increase of at least 1 point. Data will be collected one week before the intervention and one week after the intervention.;An improvement in fatigue perception is expected, evaluated by the "Manchester COPD Fatigue Scale" increase of at least 4.89 points. Data will be collected one week before the intervention and one week after the intervention.;An improvement in the perception of quality of life is expected, evaluated by the "Saint George's Respiratory Questionnaire," with an increase of at least 4% in its total score. Data will be collected one week before the intervention and one week after the intervention.;An improvement in anxiety and depression is expected, evaluated by | — |
Countries
Brazil
Contacts
Public ContactAnderson José
Universidade Federal de Juiz de Fora
Outcome results
None listed